GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
90.59
+0.30 (0.33%)
Jul 2, 2025, 10:50 AM - Market open
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$330,143
Profits / Employee
-$38,576
Market Cap
2.58B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Dec 31, 2020 | 872 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
WGS News
- 7 days ago - GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics - Business Wire
- 8 days ago - GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability - Business Wire
- 15 days ago - WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 5 weeks ago - GeneDx to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale - Business Wire
- 6 weeks ago - GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip - Seeking Alpha
- 7 weeks ago - GeneDx: Time To Buy The Dip - Seeking Alpha
- 2 months ago - GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire